Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Notes Payables (2020 - 2021)

Historic Notes Payables for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2021 value amounting to $22754.0.

  • Mainz Biomed's Notes Payables fell 722.88% to $22754.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $22754.0, marking a year-over-year decrease of 722.88%. This contributed to the annual value of $22754.0 for FY2021, which is 722.88% down from last year.
  • As of Q4 2021, Mainz Biomed's Notes Payables stood at $22754.0, which was down 722.88% from $24527.0 recorded in Q4 2020.
  • Mainz Biomed's 5-year Notes Payables high stood at $24527.0 for Q4 2020, and its period low was $22754.0 during Q4 2021.